Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02131428 · ClinicalTrials.gov registry record
Depression and Heart Failure Disease Progression
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 186
- Enrollment target
NCT02131428 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 186 participants.
The verdict
NCT02131428 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 186 participants
- Enrollment target
Study Summary
Heart failure is the most costly diagnosis in the Medicare population. Clinical depression is strikingly common in heart failure patients, and not only diminishes their quality of life, but also is associated with a markedly increased risk of hospitalization or death. This study is designed to further our understanding of the behavioral and biological effects of depression in patients with heart failure, so that appropriate treatments can be developed.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 186 participants |
| Start Date | 2014-11 |
| Est. Completion | 2021-12-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02131428
The ClinicalTrials.gov registry entry for NCT02131428 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 186 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02131428 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02131428 about?
NCT02131428 is a clinical study titled "Depression and Heart Failure Disease Progression". Heart failure is the most costly diagnosis in the Medicare population. Clinical depression is strikingly common in heart failure patients, and not only diminishes their quality of life, but also is associated with a markedly increased risk of hospitalization or death. This study is designed to furth...
What is the current status of trial NCT02131428?
This trial is currently completed. The enrollment target is 186 participants. The study started on 2014-11. Estimated completion is 2021-12-01.
Who is sponsoring clinical trial NCT02131428?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.